Furthermore, Hck and Fgr expression are highly correlated (Supporting Information S1 Fig), suggesting that the subset of AML patients dependent on Src-family kinase signaling will be most susceptible to selective inhibitors of these kinases. The gene discussed is HCK; the disease is acute myeloid leukemia.